Drug Shortage Report for SANDOZ-CARBAMAZEPINE CR

Last updated on 2024-12-03 History
Report ID 239131
Drug Identification Number 02261839
Brand name SANDOZ-CARBAMAZEPINE CR
Common or Proper name CARBAMAZEPINE CR
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 200MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100MRT
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-10-02
Estimated end date 2024-11-29
Actual end date 2024-12-02
Shortage status Resolved
Updated date 2024-12-03
Company comments Product available under allocation.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2024-12-03 English Compare
v16 2024-12-02 French Compare
v15 2024-12-02 English Compare
v14 2024-11-25 French Compare
v13 2024-11-25 English Compare
v12 2024-11-18 French Compare
v11 2024-11-18 English Compare
v10 2024-11-11 French Compare
v9 2024-11-11 English Compare
v8 2024-11-11 French Compare
v7 2024-11-11 English Compare
v6 2024-10-15 French Compare
v5 2024-10-15 English Compare
v4 2024-10-03 English Compare
v3 2024-10-02 French Compare
v2 2024-10-02 English Compare
v1 2024-10-02 English Compare

Showing 1 to 17 of 17